Bosh sahifaAMGN • NASDAQ
add
Amgen
305,69 $
Seans yopilganidan keyin:(0,00%)0,00
305,69 $
Yopilgan:22-iyl, 17:11:18 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
295,87 $
Kunlik diapazon
295,86 $ - 306,80 $
Yillik diapazon
253,30 $ - 346,85 $
Bozor kapitalizatsiyasi
164,37 mlrd USD
Oʻrtacha hajm
2,47 mln
Narx/foyda
27,90
Dividend daromadliligi
3,11%
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 8,15 mlrd | 9,43% |
Joriy xarajat | 3,20 mlrd | 0,47% |
Sof foyda | 1,73 mlrd | 1 630,97% |
Sof foyda marjasi | 21,23 | 1 496,71% |
Har bir ulushga tushum | 4,90 | 23,74% |
EBITDA | 3,52 mlrd | 19,29% |
Amaldagi soliq stavkasi | 12,32% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 8,81 mlrd | -9,25% |
Jami aktivlari | 89,37 mlrd | -3,89% |
Jami passivlari | 83,16 mlrd | -5,45% |
Umumiy kapital | 6,21 mlrd | — |
Tarqatilgan aksiyalar | 537,71 mln | — |
Narxi/balansdagi bahosi | 25,64 | — |
Aktivlardan daromad | 6,46% | — |
Kapitaldan daromad | 8,98% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,73 mlrd | 1 630,97% |
Operatsiyalardan naqd pul | 1,39 mlrd | 101,89% |
Sarmoyadan naqd pul | -447,00 mln | -105,99% |
Moliyadan naqd pul | -4,11 mlrd | -140,46% |
Naqd pulning sof oʻzgarishi | -3,16 mlrd | -155,91% |
Boʻsh pul | 1,21 mlrd | -34,48% |
Haqida
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue.
The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp Wikipedia
Tashkil etilgan
8-apr, 1980
Sayt
Xodimlar soni
28 000
